Jeremy joined us in July 2022 as an Associate from Rothschild & Co where he was an Investment Banking Analyst covering healthcare. Prior to that, Jeremy worked for Silverpeak as an analyst covering healthcare and technology. He also co-founded Nanomed, a startup utilising carbon nanostructures for drug delivery. Jeremy graduated with an engineering degree from Imperial College and two masters from Cambridge University. He is located in London and will focus on K2 HealthVentures and targets in the Life Science Tools sector.